Wellwoman Health Insurance

Cover for seven female-specific cancers

Brady Insurance can now offer a great new Wellwoman protection product from Chartis Insurance. It offers a serious illness cover in the event of diagnosis of female specific cancers and male specific cancers of up to €50,000.

The WellWoman Plan is designed to help you when you need it the most. So if you get sick with one of these covered illnesses, the policy will help you financially so you have one less thing to worry about and can concentrate on your treatment and getting better.

GET A QUOTE NOW -

http://www.chartisdirect.ie/brady-insurance_1189_330662.html

There are no restrictions on how you spend the money, it could help pay for child care, help around the home, and even the little things you take for granted like getting to the shops or the doctors. It can also be used to help pay your medical bills or on a relaxing holiday to help you recuperate.

There’s no medical examination, no awkward health questions and no exclusions due to family history. Claims can be made just 90 days after taking out your Plan.

• Cash payment of €25,000 on diagnosis with Standard Cover
• Cash payment of €50,000 on diagnosis with Premier Cover
• OR €1,000 day case surgery benefit for carcinoma in situ [early stage cancer in which the disease is confined to cells where it first appeared] of a covered organ other than the breast.
• Guaranteed acceptance for women aged between 18 and 69* years and resident in the Republic of Ireland
• Care Advisory Service and Medical Helpline
• Cover regardless of your family's medical history
• We will pay your first month's premium
• FREE €150 Holiday Voucher
  
  Insurance provided by Chartis Insurance Ireland Limited

  *Terms and Conditions available for persons outside this criteria on request

  This product does not cover;

  • cancers you have had before or those due to any pre-existing medical conditions

  • cancers diagnosed within the first 90 days of your policy
  • any tumours which are histologically diagnosed as pre-malignant